Nengtai Ouyang Selected Research

nitroxy-butyl-acetylsalicylic acid

6/2011	Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action.
9/2008	NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts.
2/2008	NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.
4/2006	Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
2/2006	NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis.
10/2005	NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.
1/2004	NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nengtai Ouyang Research Topics

Disease

30	Neoplasms (Cancer) 09/2023 - 01/2004
12	Colonic Neoplasms (Colon Cancer) 08/2014 - 01/2004
9	Carcinogenesis 02/2019 - 01/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 04/2006
5	Breast Neoplasms (Breast Cancer) 04/2019 - 04/2005
4	Papillary Thyroid Cancer 01/2021 - 01/2017
3	Lung Neoplasms (Lung Cancer) 12/2014 - 04/2013
3	Necrosis 09/2008 - 03/2003
3	Reperfusion Injury 10/2004 - 03/2004
2	Squamous Cell Carcinoma of Head and Neck 11/2022 - 09/2022
2	Lymphatic Metastasis 01/2021 - 02/2019
2	Contusions 01/2021 - 11/2008
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 06/2009
2	Inflammation (Inflammations) 03/2020 - 01/2012
2	Carcinoma (Carcinomatosis) 01/2018 - 04/2006
2	Neoplasm Metastasis (Metastasis) 01/2017 - 03/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2014 - 08/2013
2	Atrophy 10/2004 - 09/2004
2	Fibrosis (Cirrhosis) 09/2004 - 03/2003
1	Epstein-Barr Virus Infections 03/2024
1	Sepsis (Septicemia) 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023
1	Leukoplakia 01/2022
1	Wallerian Degeneration 01/2021
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Knee Osteoarthritis 03/2020
1	Osteoarthritis 03/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019
1	Osteoporosis 09/2018
1	Metabolic Bone Diseases (Osteopenia) 09/2018
1	Postmenopausal Osteoporosis 09/2018
1	Osteolysis 09/2018

Drug/Important Bio-Agent (IBA)

10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2016 - 01/2004
7	Sulindac (Copal)FDA LinkGeneric 05/2015 - 10/2010
7	nitroxy-butyl-acetylsalicylic acidIBA 06/2011 - 01/2004
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2015 - 06/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2011 - 02/2006
3	Small Interfering RNA (siRNA)IBA 01/2018 - 03/2003
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2004
3	CateninsIBA 01/2015 - 06/2011
3	nitroaspirinIBA 06/2006 - 01/2004
2	RNA (Ribonucleic Acid)IBA 09/2023 - 08/2014
2	EnzymesIBA 01/2021 - 10/2005
2	AntigensIBA 03/2020 - 02/2019
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2017
2	Hormones (Hormone)IBA 09/2016 - 04/2005
2	MicroRNAs (MicroRNA)IBA 09/2016 - 08/2014
2	Ibuprofen (Motrin)FDA LinkGeneric 12/2014 - 02/2013
2	2-(4-isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl esterIBA 12/2014 - 02/2013
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2013 - 01/2013
2	HydrogelsIBA 06/2013 - 10/2012
2	Interleukin-10 (Interleukin 10)IBA 06/2013 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 06/2013 - 01/2012
2	Dinoprostone (PGE2)FDA Link 04/2013 - 06/2006
2	Indomethacin (Indometacin)FDA LinkGeneric 04/2013 - 06/2006
2	AzoxymethaneIBA 02/2013 - 06/2006
2	Prostaglandins EIBA 02/2013 - 01/2012
2	ProstaglandinsIBA 01/2012 - 02/2004
2	Eflornithine (Ornidyl)FDA Link 07/2011 - 10/2010
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2011 - 06/2006
2	NF-kappa B (NF-kB)IBA 02/2008 - 04/2006
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2006 - 02/2004
1	AntibodiesIBA 03/2024
1	Epstein-Barr virus early antigenIBA 03/2024
1	Tyrosine Kinase InhibitorsIBA 12/2023
1	erdafitinibIBA 09/2023
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 09/2023
1	duvelisibIBA 09/2023
1	Serine (L-Serine)FDA Link 09/2023
1	Small Cytoplasmic RNAIBA 09/2023
1	Immune Checkpoint InhibitorsIBA 11/2022
1	N-methyladenosineIBA 11/2022
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2022
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2022
1	Sorbitol (Yal)FDA Link 01/2021
1	sorbinilIBA 01/2021
1	L-Iditol 2-Dehydrogenase (L Iditol 2 Dehydrogenase)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	FructoseIBA 01/2021
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2021
1	polyolIBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 03/2020
1	ABO Blood-Group SystemIBA 03/2020
1	taxaneIBA 04/2019
1	AnthracyclinesIBA 04/2019
1	squamous cell carcinoma-related antigenIBA 02/2019
1	Zoledronic Acid (Zometa)FDA Link 09/2018
1	Teriparatide (Parathar)FDA Link 09/2018
1	Anabolic AgentsIBA 09/2018
1	Bone Density Conservation AgentsIBA 09/2018
1	salicylhydroxamic acid (SHAM)IBA 09/2018

Therapy/Procedure

4	Therapeutics 09/2023 - 08/2013
4	Injections 07/2016 - 03/2003
3	Immunotherapy 11/2022 - 04/2017
2	Drug Therapy (Chemotherapy) 10/2013 - 04/2005
1	Critical Care (Surgical Intensive Care) 03/2024
1	Thyroidectomy 01/2021
1	Ovariectomy (Oophorectomy) 09/2018
1	Arthroplasty 09/2018
1	Subcutaneous Injections 09/2018